Overview

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

Status:
RECRUITING
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen
Phase:
PHASE2
Details
Lead Sponsor:
Peking Union Medical College Hospital